CLINICAL_TRIALS
trial_result
· 2016-01-25
Clinical Trial Update: Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma [Phase 2]
Summary
Phase II trial of pemetrexed (Alimta) in advanced thymoma and thymic carcinoma completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Joseph Loehrer Sr. | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-25